Entrepreneurial Spirit, Rooted in Tradition. At Mitsubishi Tanabe Pharma America, Inc. (MTPA), we can tout a storied reputation more than 300 years in the making. Our parent company, Mitsubishi Tanabe Pharma Corporation, is a research-driven pharmaceutical company with global reach – and one of Japan’s oldest and most respected companies.
With the recent FDA approval and availability in the U.S. of RADICAVA® (edaravone) MTPA is rapidly expanding our operation across all functional areas to launch this new product in the U.S. market. Concurrently, the company is expanding its research efforts and exploring collaborations with partners to discover and bring treatments to market for unmet medical needs including orphan diseases. We currently seek motivated professionals who share our vision of scientific excellence, innovation, and unwavering dedication to improving the lives of patients.
The Director, Sales will establish and execute a plan to meet and exceed sales expectations of edaravone (MCI-186), an innovative solution approved in Japan and granted Orphan Drug status by the FDA for patients suffering from Amyotrophic Lateral Sclerosis (ALS), and for future launch brands and product acquisitions. As part of a commercial organization, the incumbent will play a critical role in shaping the sales function and strategy.
The Director, Sales will hire, develop and lead the field sales organization and will work effectively within the broader team to ensure seamless alignment and execution of the broader organization goals and launch plan objectives. The position will require 50% – 60% travel and must be based within 1 hour of a major airport.